,i  #aae? ,,congress  #b;d ,session  ,h4
 ,r4 #eibg  ,,9 ,,! ,,h\se ,,(          
,,repres5tatives  ,may #bc1 #bjah,mr4   
,soto 7= himself & ,mr4 ,fitzpatrick7   
introduc$ ! foll[+ bill2 :i* 0 ref]r$ to
 ! ,committee on ,en]gy & ,comm]ce  ,a  
,,bill  ,to am5d ! ,public ,heal?       
,s]vice ,act to exp&1 int5sify1 &       
coord9ate rese>* & o!r activities ( !   
,national ,in/itutes ( ,heal? ) respect 
to pr5atal opioid exposure & neonatal   
ab/95ce syndrome4  #a4 ,%ort title ,?is 
,act may be cit$ z ! ,neonatal ,ab/95ce 
,syndrome ,be/ ,practice ,act4  #b4     
,rese>* on pr5atal opioid exposure &    
neonatal ab/95ce syndrome ,"p ,b ( title
 ,,iv ( ! ,public ,heal? ,s]vice ,act is
 am5d$ by ins]t+ aft] section #dji;,j   
7#db ,u4,s4,c4 #bhdq7 ! foll[+ new      
section3  #dji,k4 ,pr5atal opioid       
exposure & neonatal ab/95ce syndrome    
7a7 ,rese>* ,! ,director ( ,,nih %all   
exp&1 int5sify1 & coord9ate rese>* & o!r
 activities ( ! ,national ,in/itutes (  
,heal? ) respect to ! prev5tion1        

id5tification1 & treatm5t ( pr5atal     
opioid exposure & neonatal ab/95ce      
syndrome4 ,su* rese>* & activities %all 
include ! evaluation ( treatm5t options1
 includ+ ) respect to--  7#a7 ! impact  
on %ort-t]m & long-t]m cl9ical outcomes 
& co/s ( ph>macological &               
non-ph>macological treatm5t options =   
infants ) opioid )drawal syndrome2 &    
7#b7 innovative c>e models to transition
 mo!rs & babies affect$ by su* exposure 
& syndrome out ( ! hospital ?r\gh       
outpati5t foll[-up programs & o!r       
int]discipl9>y po/-dis*>ge programs4    
7b7 ,be/ practices ,bas$ on ! rese>* &  
activities conduct$ pursuant to         
subsection 7a71 ! ,director ( ,,nih     
%all--  7#a7 e/abli%1 & update z        
necess>y1 be/ practices = scre5+ &      
treat+ pregnant wom5 = opioid use       
disord] & = scre5+ = neonatal ab/95ce   
syndrome & opioid )drawal syndrome among
 infants expos$ to opioids dur+         
pregnancy2 &  7#b7 dissem9ate su* be/   
practices to int]e/$ /akehold]s4  4